UT Health San Antonio, University Health Trial Shows Bionic Pancreas Improves Type 1 Diabetes Management Compared To Standard Insulin Delivery Methods
September 29, 2022
September 29, 2022
SAN ANTONIO, Texas, Sept. 29 (TNSjou) -- The University of Texas Health Science Center at San Antonio issued the following news release:
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at UT Health San A . . .
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at UT Health San A . . .